TScan Therapeutics (TCRX) Stock Chart & Stock Price History $2.40 -0.06 (-2.44%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TScan Therapeutics Stock Price Performance 5 Day Performance-11.76%1 Month Performance-17.24%3 Month Performance-55.31%6 Month Performance-65.32%Year-To-Date Performance-21.05%1 Year Performance-54.37% Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address TCRX Stock Chart for Saturday, January, 18, 2025 TCRX Chart by TradingView TScan Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$2.46$2.40-2.44%$2.50$2.38236,538 shs$128.09 million01/16/2025$2.65$2.46-7.17%$2.64$2.44187,693 shs$131.29 million01/15/2025$2.63$2.65+0.76%$2.74$2.63124,190 shs$141.43 million01/14/2025$2.72$2.63-3.31%$2.85$2.60250,618 shs$140.37 million01/13/2025$2.77$2.72-1.81%$2.83$2.65350,065 shs$145.17 million01/10/2025$2.85$2.77-2.81%$2.80$2.61744,732 shs$147.84 million01/09/2025$2.85$2.85$3.00$2.79371,938 shs$152.11 million01/08/2025$3.01$2.85-5.32%$3.00$2.79371,938 shs$152.11 million01/07/2025$2.98$3.01+1.01%$3.07$2.95272,914 shs$160.65 million01/06/2025$3.07$2.98-2.93%$3.13$2.98699,316 shs$159.05 million Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/03/2025$3.09$3.07-0.65%$3.21$3.05315,306 shs$163.85 million01/02/2025$3.04$3.09+1.64%$3.18$3.03471,024 shs$164.92 million01/01/2025$3.04$3.04$3.12$2.95489,461 shs$162.25 million12/31/2024$3.00$3.04+1.33%$3.12$2.95489,461 shs$162.25 million12/30/2024$3.06$3.00-1.96%$3.10$2.95469,274 shs$160.11 million12/27/2024$3.11$3.06-1.61%$3.17$2.95448,339 shs$163.32 million12/26/2024$2.91$3.11+6.87%$3.43$2.963.42 million shs$165.98 million12/25/2024$2.91$2.91$3.01$2.88129,092 shs$155.31 million12/24/2024$3.01$2.91-3.32%$3.01$2.88129,092 shs$155.31 million12/23/2024$2.97$3.01+1.35%$3.10$2.92281,392 shs$160.65 million12/20/2024$2.93$2.97+1.37%$3.05$2.87891,814 shs$158.51 million12/19/2024$2.90$2.93+1.03%$3.03$2.85275,595 shs$156.38 million12/18/2024$2.97$2.90-2.36%$3.10$2.81447,005 shs$154.78 million12/17/2024$3.01$2.97-1.33%$3.15$2.91394,876 shs$158.51 million Related Companies VectivBio Stock Chart Kura Oncology Stock Chart Tectonic Therapeutic Stock Chart CARGO Therapeutics Stock Chart Humacyte Stock Chart Annexon Stock Chart Pharvaris Stock Chart Keros Therapeutics Stock Chart Mereo BioPharma Group Stock Chart Rapport Therapeutics Stock Chart Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TCRX Stock Alerts